All > Vaccine

Q CAN PLUS for Immune Response

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Immune Response+2 MoreQ CAN PLUS - DietarySupplement
Eligibility
65 - 80
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether Q CAN PLUS powder can improve immune, inflammatory, and cognitive function.

Eligible Conditions
  • Immune Response
  • Inflammation
  • Cognitive Impairment

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Aspirin
1
Almond
1
Cogni.Q

Study Objectives

8 Primary · 2 Secondary · Reporting Duration: week 16 to week 20

baseline to week 16
Changes from baseline in global cognitive composite score
Changes in complete blood count (CBC) and differential count
Changes in immune status measurements
Changes in inflammatory factors and cytokines
Changes in lymphocyte activity and cytokine production
Body Weight Changes
Changes in natural killer (NK) cell activity
baseline to week 20
Changes in the upper respiratory infection questionnaire score
Week 20
Changes in neutralizing antibody titers against hemagglutinin and neuraminidase of the vaccine strain.
Changes in the viral load in response to vaccination

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Aspirin
1
Almond
1
Cogni.Q

Trial Design

2 Treatment Groups

Q CAN PLUS POWDER
1 of 2
Placebo
1 of 2

Experimental Treatment

Non-Treatment Group

62 Total Participants · 2 Treatment Groups

Primary Treatment: Q CAN PLUS · Has Placebo Group · N/A

Q CAN PLUS POWDER
DietarySupplement
Experimental Group · 1 Intervention: Q CAN PLUS · Intervention Types: DietarySupplement
Placebo
DietarySupplement
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: DietarySupplement
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Q CAN PLUS
2018
N/A
~30

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: week 16 to week 20

Who is running the clinical trial?

Loma Linda UniversityLead Sponsor
285 Previous Clinical Trials
257,964 Total Patients Enrolled
Joan Sabate, DrPHPrincipal InvestigatorLoma Linda University
4 Previous Clinical Trials
55,969 Total Patients Enrolled

Eligibility Criteria

Age 65 - 80 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have an age of 65 years or older.
You are ambulatory.
You live in or around Loma Linda and you can commute to the Nutrition Research Center.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top